Agilent Technologies, Inc. $A Shares Sold by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 25.0% during the first quarter, Holdings Channel.com reports. The firm owned 3,497,319 shares of the medical research company’s stock after selling 1,167,562 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Agilent Technologies were worth $398,609,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in A. Bridgefront Capital LLC purchased a new position in Agilent Technologies in the third quarter worth $1,323,000. Wellington Management Group LLP boosted its position in shares of Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Agilent Technologies by 4.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares in the last quarter. Champlain Investment Partners LLC grew its stake in shares of Agilent Technologies by 33.3% during the 3rd quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after purchasing an additional 223,750 shares during the period. Finally, Andra AP fonden grew its stake in shares of Agilent Technologies by 32.5% during the 3rd quarter. Andra AP fonden now owns 132,900 shares of the medical research company’s stock worth $17,058,000 after purchasing an additional 32,600 shares during the period.

More Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent completed its acquisition of Biocare Medical, strengthening its diagnostics and clinical pathology offerings and potentially improving long-term growth prospects. Agilent finalizes Biocare Medical takeover
• Positive Sentiment: Sanford C. Bernstein initiated coverage with an outperform rating and a $155 price target, which may bolster investor confidence in additional share price upside. Benzinga coverage
• Positive Sentiment: Recent commentary highlights Agilent’s post-earnings resilience, reflecting steady investor interest after the company beat expectations and raised/confirmed guidance. Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
• Neutral Sentiment: Piper Sandler initiated coverage at Neutral with a $150 target, which is supportive but less bullish than Bernstein’s call. Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
• Neutral Sentiment: Articles about dividend reliability and broader adoption of Agilent software suggest steady fundamentals, but they are less likely to drive a major near-term stock move. Is Agilent Technologies (NYSE:A) Still A Reliable Dividend Story? Shanghai ICRD Adopts Agilent Software
• Neutral Sentiment: Agilent’s stock has been trading with modest strength following the earnings release, but the move appears tied more to execution and sentiment than to any single dramatic catalyst. Agilent (A) stock trades up, here is why

Analyst Upgrades and Downgrades

Several brokerages recently commented on A. Morgan Stanley reduced their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Piper Sandler initiated coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Robert W. Baird increased their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Finally, Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $160.88.

Agilent Technologies Trading Up 0.6%

Shares of A stock opened at $136.29 on Friday. The stock has a market cap of $38.49 billion, a P/E ratio of 27.37, a P/E/G ratio of 2.42 and a beta of 1.26. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The business has a fifty day simple moving average of $122.86 and a 200-day simple moving average of $126.32.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.